Page 1 | Search Results | Journal of Experimental Medicine

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Impact of checkpoint blockade on cancer vaccine–activated CD8⁺ T cell responses

In Special Collection:

JEM 2020 Update on Cancer Immunology and Immunotherapy

Patricia M. Santos, Juraj Adamik, Timothy R. Howes, Samuel Du, Lazar Vujanovic, Sarah Warren, Andrea Gambotto, John M. Kirkwood, Lisa H. Butterfield

J Exp Med (2020) 217 (7): e20191369.

https://doi.org/10.1084/jem.20191369

Published: 05 May 2020

View article titled, Impact of checkpoint blockade on cancer vaccine–activated CD8+ T cell responses

Includes: Supplementary data

Journal Articles

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8⁺ T cell dysfunction in melanoma patients

Julien Fourcade, Zhaojun Sun, Mourad Benallaoua, Philippe Guillaume, Immanuel F. Luescher, Cindy Sander, John M. Kirkwood, Vijay Kuchroo, Hassane M. Zarour

J Exp Med (2010) 207 (10): 2175–2186.

https://doi.org/10.1084/jem.20100637

Published: 06 September 2010

View article titled, Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

Includes: Supplementary data

Journal Articles

IL-18–induced CD83⁺CCR7⁺ NK helper cells

Robbie B. Mailliard, Sean M. Alber, Hongmei Shen, Simon C. Watkins, John M. Kirkwood, Ronald B. Herberman, Pawel Kalinski

J Exp Med (2005) 202 (7): 941–953.

https://doi.org/10.1084/jem.20050128

Published: 03 October 2005

View article titled, IL-18–induced CD83 + CCR7 + NK helper cells

Journal Articles

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4 ⁺ T Cell Responses Against MAGE-6 in HLA-DRB10401 ⁺ Patients With Renal Cell Carcinoma or Melanoma

Tomohide Tatsumi, Lisa S. Kierstead, Elena Ranieri, Loreto Gesualdo, Francesco P. Schena, James H. Finke, Ronald M. Bukowski, Jan Mueller-Berghaus, John M. Kirkwood, William W. Kwok, Walter J. Storkus

J Exp Med (2002) 196 (5): 619–628.

https://doi.org/10.1084/jem.20012142

Published: 26 August 2002

View article titled, Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4 + T Cell Responses Against MAGE-6 in HLA-DRB10401 + Patients With Renal Cell Carcinoma or Melanoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Date

Impact of checkpoint blockade on cancer vaccine–activated CD8⁺ T cell responses

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8⁺ T cell dysfunction in melanoma patients

IL-18–induced CD83⁺CCR7⁺ NK helper cells

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4 ⁺ T Cell Responses Against MAGE-6 in HLA-DRB10401 ⁺ Patients With Renal Cell Carcinoma or Melanoma

Email alerts

Update search

Impact of checkpoint blockade on cancer vaccine–activated CD8+ T cell responses

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

IL-18–induced CD83 + CCR7 + NK helper cells

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4 + T Cell Responses Against MAGE-6 in HLA-DRB10401 + Patients With Renal Cell Carcinoma or Melanoma

Email alerts

This Feature Is Available To Subscribers Only

Impact of checkpoint blockade on cancer vaccine–activated CD8⁺ T cell responses

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8⁺ T cell dysfunction in melanoma patients

IL-18–induced CD83⁺CCR7⁺ NK helper cells

Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4 ⁺ T Cell Responses Against MAGE-6 in HLA-DRB10401 ⁺ Patients With Renal Cell Carcinoma or Melanoma